Results 261 to 270 of about 68,243 (289)

A heart failure network model to improve outcome and trans‐sectoral guideline‐directed medical treatment utilization

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure (HF) is a major cause of hospitalization, mortality and healthcare costs. Reducing its socioeconomic burden is a key global public health priority. HF networks are recommended to improve screening and management of HF patients.
Christina Paitazoglou, Dominik Jurczyk, Matthias Mezger, Felicitas Lemmer, Bernhard Schwaab, Patricia Grube, Thomas Helms, Bettina Zippel‐Schultz, Buntaro Fujita, Roland Tilz, Thomas Stiermaier, Christian Frerker, Stephan Ensminger, Ingo Eitel   +13 more
wiley   +1 more source

Correction: Cost-effectiveness of Left Ventricular Assist Devices (LVADs) as destination therapy in the UK: An economic modelling study. [PDF]

PLoS One
Avşar TS, Jackson L, Barton P, Beese S, Lim HS, Quinn D, Price M, Moore DJ.   +7 more
europepmc   +1 more source

Right ventricular function and left ventricular assist device placement: clinical considerations and outcomes.

, 2010
Romeo A Lainez, Gene Parrino, Michael Bates   +2 more
openalex   +1 more source

Worsening versus advanced heart failure: Management and challenges

ESC Heart Failure, EarlyView.
Clinical feature, circulating biomarkers and therapeutic management of patients with WHF versus AdvHF. Abbreviations: AdvHF, advanced heart failure; HF, heart failure; HTx, heart transplant; GDMT, guideline‐directed medical therapy; MCS, mechanical circulatory support; NYHA, New York Heart Association; WHF, worsening heart failure.
Alberto Palazzuoli, Marco Giuseppe Del Buono, Giulia La Vecchia, Stephen J. Greene, Andrew P. Ambrosy, Ovidiu Chioncel, Finn Gustafsson, Selim R. Krim, Carl J. Lavie, Marianna Adamo, Tuvia Ben Gal, Oliviana Geavlete, Laura Antohi, Giuseppe Rosano, Sean Collins, Filippo Crea   +15 more
wiley   +1 more source

Epidemiology and impact of device-specific infections on patients receiving left ventricular assist devices. [PDF]

JHLT Open
Iyengar A, Feinman J, Jiang J, Song C, Kim S, Mathew A, Golec S, Rao A, Radakrishnan A, Asher M, Rekhtman D, DePaolo J, Moss N, Itagaki S, Anyanwu A, Wald J, Cevasco M, Parikh A.   +17 more
europepmc   +1 more source

Outcomes following isolated right ventricular assist device as durable support for primary right heart failure: An INTERMACS analysis

Edo Y. Birati, E. Wilson Grandin, Robert Zhang, Fausto Cabezas, Keshava Rajagopal, Matthew Seigerman, Allison Padegimas, Jeremy A. Mazurek, Matthew C. Kiernan, Navin K. Kapur, Pavan Atluri, Guilherme H. Oliveira, Francis D. Pagani, S.L. Myers, Jeffrey J. Teuteberg, Robert L. Kormos, James K Kirklin, Michael A. Acker, J. Eduardo Rame   +18 more
openalex   +1 more source

Use of artificial intelligence for detecting left ventricular dysfunction and predicting incident heart failure risk

ESC Heart Failure, EarlyView.
Abstract Effective medications are available for the prevention of heart failure (HF). While their use is indicated in patients with risk factors, engagement and adherence among ‘at risk’ individuals is challenging, as it is with atherosclerotic heart disease prevention.
Anna Węgrzyn‐Witek, Monika Przewlocka‐Kosmala, Wojciech Kosmala, Thomas H. Marwick   +3 more
wiley   +1 more source

Cardiac Contractility Modulation as bridge to recovery in a patient with advanced heart failure evaluated for left ventricular assist devices: a case report and review of literature. [PDF]

Front Cardiovasc Med
Menichetti F, Solari M, Salvetti E, Guarnaccia V, Girasole T, Venturi F, Del Rosso A.   +6 more
europepmc   +1 more source

Long‐term prognosis of pure and impure tachycardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Background and aims Tachycardia‐induced cardiomyopathy (TCM) is a reversible form of heart failure (HF) driven by arrhythmias, often atrial fibrillation (AF). While reversible, TCM's long‐term prognosis remains unclear, especially in comparison to HF with reduced ejection fraction (HFrEF).
Giulia Stronati, Michele Alfieri, Niki Tombolesi, Alessandro Barbarossa, Samuele Principi, Federico Gullì, Arianna Massari, Gianmarco Bastianoni, Francesca Roccetti, Michela Casella, Antonio Dello Russo, Federico Guerra   +11 more
wiley   +1 more source

Outcomes of Left Ventricular Assist Devices as Destination Therapy: A Systematic Review with Meta-Analysis. [PDF]

Life (Basel)
Khoufi EAA.
europepmc   +1 more source